Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 May 5, 2026 8:00 AM EDT
Company Participants
Charles Liles - Associate Director and Head of Corporate Communications & Investor Relations
Bassil Dahiyat - Co-Founder, CEO, President & Director
John Desjarlais - Executive VP of Research & Chief Scientific Officer
Mark Osterman - Senior Vice President of Clinical Development (Autoimmune)
Dane Leone - Executive VP & Chief Strategy Officer
Conference Call Participants
Vipul Jairath
Albert Agustinus - Leerink Partners LLC, Research Division
Ikenna Okafor - TD Cowen, Research Division
Etzer Darout - Barclays Bank PLC, Research Division
Timur Ivannikov - Cantor Fitzgerald & Co., Research Division
Sean McCutcheon - Raymond James & Associates, Inc., Research Division
Gregory Renza - Truist Securities, Inc., Research Division
Madeleine Stone - William Blair & Company L.L.C., Research Division
Eva Fortea-Verdejo - Wells Fargo Securities, LLC, Research Division
Matthew Guggenbiller - BofA Securities, Research Division
Presentation
Operator
Hello, and welcome to the Xencor DDW 2026 Webcast. [Operator Instructions] Also, reminder, this conference is being recorded today. If you have any objections, please disconnect at this time.
I will now turn the call over to Charles Liles.
Charles Liles
Associate Director and Head of Corporate Communications & Investor Relations
Thank you, and good morning. Yesterday, we issued a press release introducing the topics we plan to discuss on this webcast, including results from the Phase I study of XmAb942 and the preclinical characterization of XmAb412. The press release is available at www.xencor.com.
Providing comments on the call from Xencor are Bassil Dahiyat, President and Chief Executive Officer; John Desjarlais, Executive Vice President and Chief Scientific Officer; Dane Leone, Executive Vice President and Chief Strategy Officer; and Mark Osterman, Senior Vice President and Head of Clinical Development for Xencor's autoimmune programs. We are also joined by Dr. Vipul Jairath, Professor of Medicine in the Division of Gastroenterology at Western University and Chief Medical Officer
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。